Risk-adapted biopsy decision based on prostate magnetic resonance imaging and prostate-specific antigen density for enhanced biopsy avoidance in first prostate cancer diagnostic evaluation.

ABSTRACT:

SUBMITTER: Schoots IG 

PROVIDER: S-EPMC7894174 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature